Onsior label

Onsior

Onsior Recall

Get an alert when a recall is issued.

Add Info

Side Effects & Adverse Reactions

Not for use in humans. Keep this and all medications out of reach of children. Consult a physician in case of accidental ingestion by humans. For use in cats only.

All cats should undergo a thorough history and physical examination before the initiation of NSAID therapy. Appropriate laboratory tests should be conducted to establish hematological and serum biochemical baseline data prior to administration of an NSAID.

Owners should be advised to observe for signs of potential drug toxicity (see Adverse Reactions and Animal Safety) and be given an “Information for Cat Owners” Sheet about ONSIOR tablets.

Do not administer ONSIOR tablets in conjunction with any other oral or injectable NSAID or corticosteroid.

Add Info

FDA Safety Alerts

There are currently no FDA safety alerts available for this drug.

Add Info

Manufacturer Warnings

There is currently no manufacturer warning information available for this drug.

Add Info

FDA Labeling Changes

There are currently no FDA labeling changes available for this drug.

Add Info

Uses

ONSIOR tablets are indicated for the control of postoperative pain and inflammation associated with orthopedic surgery, ovariohysterectomy and castration, in cats > 5.5 lbs (2.5 kg) and > 4 months of age; for up to a maximum of 3 days.

Add Info

History

There is currently no drug history available for this drug.

Add Info

Other Information

ONSIOR (robenacoxib) is a non-narcotic, non-steroidal anti-inflammatory drug (NSAID) of the coxib class. Tablets are round, beige to brown in color, not scored, flavored and contain 6 mg robenacoxib. The molecular weight of robenacoxib is 327.28.  The empirical formula is C16-H13-F4-NO2.  Robenacoxib is [5-Ethyl-2-(2,3,5,6-tetrafluoro-phenylamino)-phenyl]-acetic acid. The structural formula is:

robenacoxib structural formula

Add Info
Add to My Alerts
Report Side Effect
Leave a Review
Navigate to :
Onsior Recall
Side Effects & Adverse Reactions
Legal Issues
FDA Safety Alerts
Manufacturer Warnings
FDA Labeling Changes
Uses
History
Other Information
Manufacturers
Trending Topics

Onsior Manufacturers

  • Novartis Animal Health Us, Inc.
    Onsior | Novartis Animal Health Us, Inc.
    No Recall

    Onsior | Novartis Animal Health Us, Inc.

    Onsior | Novartis Animal Health Us, Inc.

    Always provide “Information for Cat Owners” Sheet with prescription. Carefully consider the potential benefits and risk of ONSIOR tablets and other treatment options before deciding to use ONSIOR tablets. Use the lowest effective dose for the shortest duration consistent with individual response.

    The dose of ONSIOR tablets is 0.45 mg/lb (1 mg/kg) orally once daily, for a maximum of three days. See dosing chart for dosage directions.

    Dosage Directions: For oral use in cats ≥ 5.5 lbs and ≥ 4 months of age; for up to a maximum of 3 days. Tablets are not scored and should not be broken.

    Body weight 6 mg ONSIOR (robenacoxib) Tablet 5.5 to 13.2 lbs
    (2.5 to 6 kg) 1 whole tablet
    once daily 13.3 to 26.4 lbs
    (6.1 to 12 kg) 2 whole tablets
    once daily

    Do not use in cats weighing less than 5.5 lbs, as cats less than 5.5 lbs cannot be accurately dosed.

    The first dose should be administered approximately 30 minutes prior to surgery, at the same time as the pre-anesthetic agents are given. ONSIOR tablets may be given with or without food.

    If a second and third dose is dispensed to the client to administer at home, doses should be dispensed in the dispensing envelope with the attached Information for Owner Sheet intact. Do not remove Information for Cat Owner Sheet. Record when the first dose was administered on the dispensing envelope. Cats weighing > 13.3 lbs may require two blister cards, each dispensed in an individual dispensing envelope.

  • Novartis Animal Health Us, Inc.
    Onsior | Novartis Animal Health Us, Inc.
    No Recall

    Onsior | Novartis Animal Health Us, Inc.

    Onsior | Novartis Animal Health Us, Inc.

    Carefully consider the potential benefits and risks of ONSIOR and other treatment options before deciding to use ONSIOR (robenacoxib) injection. Use the lowest effective dose for the shortest duration consistent with individual response. It is recommended as good aseptic practice to clean stopper surface with isopropyl alcohol before and after each insertion of a needle.

    The dose of ONSIOR (robenacoxib) injection is 0.91 mg/lb (2 mg/kg) subcutaneously once daily, for a maximum of 3 days.

    Dosage Directions: For subcutaneous injection in cats ≥ 4 months of age; for up to a maximum of 3 days. To ensure accuracy of dosing, the use of a 1 mL graduated syringe is recommended. The first dose should be administered approximately 30 minutes prior to surgery, at the same time as the preanesthetic agents are given.

    Subsequent doses can be given via subcutaneous injection, or interchanged with the oral tablet in cats ≥ 5.5 lbs and ≥ 4 months of age, for a maximum of 3 total ONSIOR doses over 3 days, not to exceed one dose per day (see Animal Safety and ONSIOR tablet product insert).

    Note the dose of ONSIOR tablets and ONSIOR injection are different.

Login To Your Free Account